Daxotel Injection 20 mg/vial contains Docetaxel Trihydrate, a powerful anticancer chemotherapy agent belonging to the taxane class. It is used for the treatment of a variety of solid tumors, including breast cancer, lung cancer, prostate cancer, stomach cancer, and head and neck cancers.

Docetaxel works by interfering with the normal function of microtubules, essential components of cell division, which prevents cancer cells from multiplying and triggers programmed cell death (apoptosis). Daxotel Injection provides a precise, intravenous formulation that allows for controlled dosing in hospital or clinical settings, making it suitable for patients requiring systemic chemotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Docetaxel, the active ingredient in Daxotel Injection, functions through:

• Stabilization of microtubules: Docetaxel binds to microtubules, preventing their depolymerization. This blocks the dynamic reorganization of the cytoskeleton required for mitosis.

• Inhibition of cell division: By preventing microtubule disassembly, Docetaxel arrests cancer cells in the G2/M phase of the cell cycle, halting proliferation.

• Induction of apoptosis: The prolonged mitotic arrest triggers programmed cell death, reducing tumor mass and preventing cancer progression.

• Anti-angiogenic effect: Docetaxel may reduce tumor vascularization, further restricting tumor growth.

This mechanism makes Daxotel Injection effective against rapidly dividing cancer cells, while minimizing effects on non-dividing normal cells.

Indications

Daxotel Injection 20 mg/vial is indicated for the treatment of:

• Breast cancer – locally advanced or metastatic, often in combination with other chemotherapeutic agents

• Non-small cell lung cancer (NSCLC) – in advanced or metastatic cases

• Prostate cancer – in combination with androgen-deprivation therapy

• Gastric cancer – advanced or metastatic stages

• Head and neck cancers – as part of combination therapy

• Other solid tumors as advised by an oncologist

It is administered under strict medical supervision due to its potency and the need for monitoring potential adverse effects.

Dosage and Administration

• Administered intravenously by trained healthcare professionals in a hospital or clinical setting.

• The dosage and schedule depend on the type of cancer, body surface area, and previous treatments.

• Pre-medication with corticosteroids is usually recommended to reduce the risk of hypersensitivity reactions.

• Close monitoring of blood counts, liver function, and kidney function is essential during treatment.

• The vial must be reconstituted and diluted according to medical guidelines before infusion.

Precautions and Safety Information

• Daxotel Injection should be used with caution in patients with liver or kidney impairment, low blood counts, or pre-existing neuropathy.

• Monitor for hypersensitivity reactions, fluid retention, or cardiac complications.

• Avoid exposure to pregnant or breastfeeding women, as Docetaxel can harm fetal development.

• Patients should be informed about the risk of myelosuppression, infections, and hair loss.

• Concomitant medications and prior chemotherapy regimens should be evaluated to prevent additive toxicity.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Myelosuppression – reduced white blood cells, red blood cells, and platelets

• Gastrointestinal symptoms – nausea, vomiting, diarrhea, or mucositis

• Fluid retention – edema or weight gain

• Hair loss (alopecia) – often temporary

• Fatigue, peripheral neuropathy, or skin reactions

• Rare but serious: severe infections, liver toxicity, cardiac events, or hypersensitivity reactions

Most side effects are managed with supportive care and dose adjustments under medical supervision.

Storage Instructions

Store Daxotel Injection 20 mg/vial in a cool, dry place, protected from light. Keep out of reach of children. Only use if the solution is prepared according to clinical protocols.

Daxotel Injection 20 mg/vial provides potent chemotherapy for managing advanced solid tumors, offering a critical option in cancer treatment protocols under professional supervision.